Mizoguchi H, Nomura Y, Fukunaga Y, Imagawa M, Ogata J
Department of Urology, Medical College of Oita, Japan.
Urol Int. 1990;45(2):65-9. doi: 10.1159/000281671.
Renal tissue and urinary kallikrein activity were studied to assess the role of the renal kallikrein-kinin system in two-kidney, one-clip hypertensive rats. Body weight, urine volume, systolic blood pressure and urinary kallikrein activity were measured in 11 hypertensive rats and 6 normotensive rats 1, 4, 8 and 12 weeks after clipping or sham operation. The hypertensive rats used in the present study had systolic blood pressures of over 180 mm Hg 12 weeks after the operation and presented polyuria with a reduction in weight gain, which placed them in the malignant hypertension category. Urinary kallikrein activity in hypertensive rats significantly decreased from 21.7 +/- 13.3 nkat/day at 1 week to 11.6 +/- 5.5 nkat/day at 12 weeks after clipping (p less than 0.05), while urinary kallikrein activity in normotensive rats significantly increased from 23.6 +/- 8.9 nkat/day at 1 week to 43.7 +/- 16.2 nkat/day at 4 weeks after the sham operation. Significant differences were observed in urinary kallikrein activity between hypertensive rats and normotensive rats 4 and 12 weeks after the operation (p less than 0.05). Renal tissue kallikrein activity from bilaterally nephrectomized kidneys was investigated 12 weeks after the operation. No significant difference in tissue kallikrein activity was found between the two kidneys of the hypertensive rats. However, tissue kallikrein activity was significantly lower in the contralateral kidney of hypertensive rats as compared to the same kidney of normotensive rats (2.13 +/- 0.73 nkat/g in hypertensive rats vs. 3.05 +/- 0.69 nkat/g in normotensive rats, p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
研究肾组织和尿激肽释放酶活性,以评估肾激肽释放酶 - 激肽系统在二肾一夹高血压大鼠中的作用。在夹闭或假手术后1、4、8和12周,测量了11只高血压大鼠和6只正常血压大鼠的体重、尿量、收缩压和尿激肽释放酶活性。本研究中使用的高血压大鼠在手术后12周收缩压超过180 mmHg,并出现多尿且体重增加减少,属于恶性高血压范畴。夹闭后,高血压大鼠的尿激肽释放酶活性从1周时的21.7±13.3 nkat/天显著降至12周时的11.6±5.5 nkat/天(p<0.05),而假手术后,正常血压大鼠的尿激肽释放酶活性从1周时的23.6±8.9 nkat/天显著增加至4周时的43.7±16.2 nkat/天。手术后4周和12周,高血压大鼠和正常血压大鼠的尿激肽释放酶活性存在显著差异(p<0.05)。术后12周研究了双侧肾切除肾脏的肾组织激肽释放酶活性。高血压大鼠的两个肾脏之间组织激肽释放酶活性无显著差异。然而,与正常血压大鼠的同一只肾脏相比,高血压大鼠对侧肾脏的组织激肽释放酶活性显著降低(高血压大鼠为2.13±0.73 nkat/g,正常血压大鼠为3.05±0.69 nkat/g,p<0.05)。(摘要截断于250字)